What Sponsors Get Wrong When Initiating an Oncology Study
By Luke Gill, Claudio Hegenberger
May 4, 2026
How CRO selection significantly influences study outcomes
6 min read
False
Advertisement
Development & Clinical
Manufacturing Viral Vectors for the Next Phase of CGT
April 30, 2026
As the sector matures, scalable vector production and robust analytical control are becoming essential to clinical and commercial success
7 min read
Trends and Challenges in Nitrosamine Testing Part Four The Regulatory Landscape
April 17, 2026
Following part two, which explored the analytical challenges involved in nitrosamine testing, our experts return to offer their top tips for building a method from scratch
2 min read
Jonathan Van-Tam on COVID’s Next Phase
By James Strachan, Julian Upton
April 14, 2026
Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19
4 min read
FDA Fast-Tracks Off-the-Shelf CAR-T for Aggressive T-Cell Cancers
April 14, 2026
WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas.
1 min read
CRISPR Therapy Raises Fetal Hemoglobin in Sickle Cell Disease
April 13, 2026
An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial
2 min read
Alzheimer’s Drug Lecanemab Works by “Switching On” the Brain’s Cleanup Cells
April 7, 2026
Study reveals Fc fragment of antibody is essential for activating microglia to clear amyloid plaques
2 min read
Human-Relevant Models Come of Age
April 6, 2026
Why vascularized tissues are gaining traction
7 min read
CAR Tregs Move Into Neurodegeneration
April 3, 2026
New review maps how engineered regulatory T cells could calm brain inflammation in Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis
1 min read
Could Mass Spec Overcome the CAR T Solid Tumor Barrier?
April 1, 2026
Joey Sheff explains how proteomics is revealing targets, guiding CAR design, and predicting function in solid tumors.
6 min read
